ArticleBMJ (Clinical research ed.)2005

Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: study conclusions do not reflect findings for celecoxib.

Joe FeczkoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.